AMP Capital Investors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-44,948
| Closed | -$27.2M | – | 811 |
|
|
2021
Q3 | $27.2M | Sell |
44,948
-1,115
| -2% | -$692K | 0.15% | 158 |
|
|
2021
Q2 | $25.7M | Sell |
46,063
-1,556
| -3% | -$788K | 0.12% | 196 |
|
|
2021
Q1 | $22.5M | Buy |
47,619
+5,721
| +14% | +$2.79M | 0.11% | 220 |
|
|
2020
Q4 | $20M | Sell |
41,898
-3,100
| -7% | -$1.67M | 0.11% | 225 |
|
|
2020
Q3 | $25.8M | Buy |
44,998
+1,173
| +3% | +$711K | 0.15% | 151 |
|
|
2020
Q2 | $26.8M | Buy |
43,825
+221
| +0.5% | +$125K | 0.17% | 145 |
|
|
2020
Q1 | $20.6M | Buy |
43,604
+5,500
| +14% | +$2.27M | 0.15% | 161 |
|
|
2019
Q4 | $14.2M | Buy |
38,104
+6,395
| +20% | +$2.15M | 0.08% | 281 |
|
|
2019
Q3 | $8.67M | Sell |
31,709
-11,967
| -27% | -$3.54M | 0.05% | 394 |
|
|
2019
Q2 | $13.6M | Buy |
43,676
+18,731
| +75% | +$6.24M | 0.07% | 280 |
|
|
2019
Q1 | $10.1M | Buy |
24,945
+3,799
| +18% | +$1.56M | 0.06% | 352 |
|
|
2018
Q4 | $7.67M | Sell |
21,146
-3,848
| -15% | -$1.41M | 0.05% | 388 |
|
|
2018
Q3 | $10.1M | Sell |
24,994
-3,101
| -11% | -$1.18M | 0.06% | 366 |
|
|
2018
Q2 | $9.69M | Sell |
28,095
-12,627
| -31% | -$3.95M | 0.05% | 382 |
|
|
2018
Q1 | $13.8M | Buy |
40,722
+7,949
| +24% | +$2.76M | 0.08% | 284 |
|
|
2017
Q4 | $12.3M | Buy |
32,773
+2,020
| +7% | +$818K | 0.07% | 322 |
|
|
2017
Q3 | $13.8M | Buy |
30,753
+8,487
| +38% | +$4.04M | 0.08% | 281 |
|
|
2017
Q2 | $11.4M | Sell |
22,266
-4,047
| -15% | -$1.77M | 0.07% | 310 |
|
|
2017
Q1 | $10.2M | Buy |
26,313
+3,947
| +18% | +$1.46M | 0.06% | 345 |
|
|
2016
Q4 | $8.36M | Buy |
22,366
+68
| +0.3% | +$25.9K | 0.05% | 394 |
|
|
2016
Q3 | $9.06M | Sell |
22,298
-3,000
| -12% | -$1.2M | 0.06% | 347 |
|
|
2016
Q2 | $8.8M | Sell |
25,298
-4,600
| -15% | -$1.77M | 0.06% | 344 |
|
|
2016
Q1 | $10.8M | Buy |
29,898
+4,060
| +16% | +$1.67M | 0.07% | 281 |
|
|
2015
Q4 | $14.2M | Buy |
25,838
+100
| +0.4% | +$54.2K | 0.1% | 224 |
|
|
2015
Q3 | $11.6M | Sell |
25,738
-2,600
| -9% | -$1.4M | 0.08% | 250 |
|
|
2015
Q2 | $14.3M | Sell |
28,338
-594
| -2% | -$290K | 0.09% | 241 |
|
|
2015
Q1 | $13.3M | Buy |
28,932
+3,600
| +14% | +$1.53M | 0.08% | 276 |
|
|
2014
Q4 | $10.3M | Buy |
25,332
+3,900
| +18% | +$1.53M | 0.06% | 331 |
|
|
2014
Q3 | $7.61M | Buy |
21,432
+787
| +4% | +$264K | 0.05% | 417 |
|
|
2014
Q2 | $5.72M | Buy |
20,645
+601
| +3% | +$178K | 0.04% | 481 |
|
|
2014
Q1 | $6.01M | Sell |
20,044
-4,128
| -17% | -$1.27M | 0.04% | 459 |
|
|
2013
Q4 | $6.72M | Buy |
24,172
+5,428
| +29% | +$1.56M | 0.05% | 446 |
|
|
2013
Q3 | $5.73M | Sell |
18,744
-6,500
| -26% | -$1.71M | 0.04% | 454 |
|
|
2013
Q2 | $5.92M | Buy |
+25,244
| New | +$5.88M | 0.05% | 433 |
|
Other funds holding REGN
PI
AMP Capital Investors's REGN Position: Q4 2021 in Review
AMP Capital Investors sold out of Regeneron Pharmaceuticals (REGN) in Q4 2021, closing a stake of 44,948 shares — an estimated $27.2M sold.
AMP Capital Investors first reported a position in REGN in Q2 2013 and held it in 34 quarters. The position peaked at $27.2M in Q3 2021. 1,080 funds tracked by Wall St. Rank hold REGN as of Q4 2021.
- AMP Capital Investors reported no remaining Regeneron Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 44,948 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $27.2M.
- AMP Capital Investors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Regeneron Pharmaceuticals position peaked at $27.2M in Q3 2021.
- 1,080 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.